Oral CBP-0276 or Placebo in Adults With Active Psoriatic Arthritis (PsA)

Clinical trial NCT07706530 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07706530
Sponsor: Clarent Biopharma, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Arthritic Psoriasis

Start date: 2026-07-01
Primary completion: 2027-02-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.